209 related articles for article (PubMed ID: 2149389)
1. Amlodipine with enalapril therapy in moderate-severe essential hypertension.
Jensen H; Garsdal P; Davies J
J Hum Hypertens; 1990 Oct; 4(5):541-5. PubMed ID: 2149389
[TBL] [Abstract][Full Text] [Related]
2. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
3. Amlodipine and captopril in moderate-severe essential hypertension.
Maclean D; Mitchell ET; Wilcox RG; Walker P; Tyler HM
J Hum Hypertens; 1988 Aug; 2(2):127-32. PubMed ID: 2977406
[TBL] [Abstract][Full Text] [Related]
4. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
5. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
Leonetti G;
Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
[TBL] [Abstract][Full Text] [Related]
6. A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. Amlodipine Study Group.
Lorimer AR; Smedsrud T; Walker P; Tyler HM
J Hum Hypertens; 1989 Jun; 3(3):191-6. PubMed ID: 2527993
[TBL] [Abstract][Full Text] [Related]
7. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
Pathak L; Hiremath ; Kerkar PG; Manade VG
J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of amlodipine and the nifedipine retard preparation in the treatment of arterial hypertension].
Pivac N; Dobovisek J; Bagatin J; Gros Furek V; Rumboldt Z; Janezić A; Kveder R; Sjerobabski V; Simunić M; Sardelić S
Lijec Vjesn; 1993; 115(11-12):356-9. PubMed ID: 8176999
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of amlodipine in patients with mild-to-moderate hypertension.
Olvera R; Samaniego V; Moguel R; Meaney E
Int J Clin Pharmacol Res; 1991; 11(5):237-41. PubMed ID: 1839988
[TBL] [Abstract][Full Text] [Related]
10. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
11. Amlodipine: a double-blind evaluation of the dose-response relationship in mild to moderate hypertension.
Frick MH; McGibney D; Tyler HM
J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S76-8. PubMed ID: 2467135
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of amlodipine, a new long-acting calcium antagonist, in mild and moderate hypertension.
Escudero J; Hernandez H
Int J Clin Pharmacol Res; 1991; 11(5):243-6. PubMed ID: 1839989
[TBL] [Abstract][Full Text] [Related]
13. Muzolimine and nitrendipine in the treatment of arterial hypertension.
de Divitiis O; Di Somma S; Petitto M; Galderisi M; Iacono C; Fazio S
Z Kardiol; 1985; 74 Suppl 2():60-5. PubMed ID: 3159163
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hypertension in the very old.
Otterstad JE; Ruilope LM
Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
16. Effects of amlodipine and enalapril on platelet function in patients with mild to moderate hypertension.
Hernández-Hernández R; Armas-Padilla MC; Velasco M; Carvajal AR; Armas de Hernández MJ; Guerrero-Pajuelo J; Pacheco B
Int J Clin Pharmacol Ther; 1999 Jul; 37(7):323-31. PubMed ID: 10442506
[TBL] [Abstract][Full Text] [Related]
17. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension.
Lorimer AR; Anderson JA; Laher MS; Davies J; Lazarus JH; Taylor SH; Sanghera S
J Hum Hypertens; 1994 Jan; 8(1):65-8. PubMed ID: 8151609
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of the antihypertensive effect of enalapril by randomized addition of different doses of hydrochlorothiazide.
Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
J Hypertens Suppl; 1985 Dec; 3(3):S483-6. PubMed ID: 2856773
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
Harder S; Rietbrock S; Thürmann P
Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
